Engineered Probiotic Protects Gut From Radiation Damage Through Melanin Production
Scientists created a melanin-producing probiotic that shields intestinal cells from radiation damage and improves gut bacteria balance.
Summary
Researchers developed an innovative probiotic therapy using genetically modified E. coli Nissle 1917 bacteria that produce melanin, a natural radioprotective compound. The engineered bacteria were encapsulated in protective microspheres that survive stomach acid and target intestinal inflammation. In studies of radiation enteritis, this probiotic treatment significantly reduced intestinal damage by preventing ferroptosis, a type of cell death involving iron and lipid damage. The therapy also improved gut microbiome balance by increasing beneficial bacteria like Akkermansia while reducing harmful species. This represents a promising new approach for protecting gut health during radiation exposure.
Detailed Summary
Radiation enteritis, intestinal inflammation caused by radiation exposure, lacks effective treatments and poses significant health risks. This study introduces a groundbreaking approach using engineered probiotics to provide targeted protection against radiation damage.
Researchers genetically modified the beneficial bacteria E. coli Nissle 1917 to produce tyrosinase, an enzyme that creates melanin - the same pigment that protects our skin from UV damage. They encapsulated these bacteria in alginate-chitosan microspheres that survive stomach acid and release the therapeutic bacteria directly in the intestines.
The engineered probiotic demonstrated remarkable protective effects against radiation-induced intestinal damage. It prevented ferroptosis, a destructive form of cell death involving iron accumulation and lipid peroxidation that contributes to radiation injury. The treatment significantly reduced DNA damage and intestinal inflammation in experimental models.
Beyond direct protection, the therapy improved gut microbiome composition by increasing beneficial bacteria like Akkermansia and Ligilactobacillus while reducing harmful Escherichia-Shigella species. This microbiome rebalancing contributes to overall intestinal health and immune function.
For longevity and health optimization, this research highlights the potential of engineered probiotics as precision therapeutics. The approach could benefit cancer patients undergoing radiation therapy, individuals with occupational radiation exposure, or those seeking enhanced cellular protection against oxidative damage. However, this remains experimental technology requiring extensive safety testing before human application.
Key Findings
- Engineered probiotic produces melanin directly in intestines for radiation protection
- Treatment prevents ferroptosis and reduces lipid peroxidation damage in gut cells
- Therapy increases beneficial Akkermansia bacteria while reducing harmful species
- Microsphere delivery system survives stomach acid and targets intestinal inflammation
- Significant reduction in DNA damage and intestinal inflammation observed
Methodology
Study used genetically engineered E. coli Nissle 1917 bacteria modified to produce tyrosinase for melanin synthesis, encapsulated in alginate-chitosan microspheres via microfluidic technology. Experimental models of radiation enteritis were used to evaluate therapeutic efficacy and mechanisms.
Study Limitations
Research appears to be in experimental stages using laboratory models rather than human trials. Safety and efficacy in humans remains unestablished, and long-term effects of genetically modified probiotics require extensive evaluation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.